FibroGen

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FibroGen and other ETFs, options, and stocks.

About FGEN

FibroGen, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It focuses on the hypoxia-inducible factor and connective tissue growth factor biology to develop medicines for the treatment of anemia, fibrotic disease, and cancer. 

CEO
Thane Wettig
CEOThane Wettig
Employees
486
Employees486
Headquarters
San Francisco, California
HeadquartersSan Francisco, California
Founded
1993
Founded1993
Employees
486
Employees486

FGEN Key Statistics

Market cap
245.43M
Market cap245.43M
Price-Earnings ratio
-0.80
Price-Earnings ratio-0.80
Dividend yield
Dividend yield
Average volume
1.64M
Average volume1.64M
High today
$2.59
High today$2.59
Low today
$2.31
Low today$2.31
Open price
$2.58
Open price$2.58
Volume
1.36M
Volume1.36M
52 Week high
$20.90
52 Week high$20.90
52 Week low
$0.3333
52 Week low$0.3333

FGEN News

Yahoo Finance 3d
FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference - Yahoo Finance

FibroGen, Inc. SAN FRANCISCO, March 26, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Thane Wettig, Chief Executive Officer, will...

FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference - Yahoo Finance
Simply Wall St 7d
FibroGen, Inc.'s Share Price Boosted 35% But Its Business Prospects Need A Lift Too - Simply Wall St

Despite an already strong run, FibroGen, Inc. ( ) shares have been powering on, with a gain of 35% in the last thirty days. But the last month did very little t...

FibroGen, Inc.'s Share Price Boosted 35% But Its Business Prospects Need A Lift Too - Simply Wall St
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.